An official club of Yeshiva University. Sponsored by Yeshiva College Student Association & affiliate
Founded in the Fall of 2014 the EBC brings the best in entrepreneurship and biotech to the interested student body. The aim of the club is to educate those with interest about the numerous opportunities present in the intersection of science and business: medical devices and technologies, research, drug development, biotech investment and more. The EBC facilitates networking between visiting scien
TOMORROW 5PM!!!
Join faculty, current students, and staff on campus to learn more about the academic and career opportunities available at The Katz School!!!
Link to register : https://events.yeshivagrad.org/event/47336 =KatzStaff&utm_medium=email&utm_content=April12kickoff
See you there!!! 😃
Yeshiva University | Event451 View upcoming dates and times for Yeshiva University.
Join us Sunday, february 26th, for our next event: a visit at the NY Hall of Science!
For more information:
https://www.facebook.com/events/1948139802088646/?notif_t=plan_user_joined¬if_id=1487628181714753
02/06/2017
The new face of healthcare: by the people for the people?
http://time.com/4649914/why-the-doctor-takes-only-cash/
What Happens When Doctors Only Take Cash Fixed-price clinics offer a glimpse at the post-Obamacare world
11/27/2016
The Entrepreneurship and Biotechnology Club recently conducted this interesting interview with biotechnology CEO, Tony Fiorino. Check it out!
Executive Column: An Interview with Noted YU Alumnus Tony Fiorino Tony Fiorino, M.D., Ph.D. has been President and CEO of Triumvira Immunologics, a cancer immunotherapy company, since December 2015. Prior to this, he was CEO at BrainStorm Cell Therapeutics from 2…
11/10/2016
Oh, and yay
http://www.fiercebiotech.com/biotech/stanford-readies-for-crispr-human-testing-after-sickle-cell-success
Stanford readies for CRISPR human testing after sickle cell success | FierceBiotech Scientists from Stanford University School of Medicine have used CRISPR in early-stage work to patch up the gene that causes sickle cell disease as they eye human trials in 2018.
11/10/2016
A ray of hope by the name of Not Hillary?
(Click on the link...looks like fiercebiotech had a change of heart
somewhere between 2 and 3am)
http://www.fiercebiotech.com/biotech/markets-slump-as-americans-vote-for-trump
Markets slump as Americans vote for Trump | FierceBiotech An audible sigh of relief was heard this morning that, at last, the U.S. 2016 election is over. In the end, in what was an oft controversial, hot-tempered and at times bewildering contest between two bitter rivals--and in what 18 months ago seemed impossible--Republican Donal Trump has become the Pr...
10/23/2016
"Mr. McDonald...introduced her to several contacts...his assistance helped her land her a job last May as a trainee at a financial-services company."
How to Cold Call Your Future Mentor Tips for networking with prospective mentors and cold calling an influential person you have never met.
09/18/2016
The opioids of the future won't get you high Instead of making pills designed to "deter abuse," several groups of scientists are working on drugs that don't get you high in the first place.
09/01/2016
http://www.wsj.com/articles/a-cure-for-swelling-drug-prices-competition-1472662484
A Cure for Swelling Drug Prices: Competition While the U.S. health care system is notoriously costly, prices of generic drugs have actually been falling. Price spikes like EpiPen’s reflect a lack of competition that can be curbed by allowing generics approved abroad to be sold in the U.S., Greg Ip writes.
08/08/2016
Interesting Read
https://www.statnews.com/2016/08/08/insider-trading-biotech/
How biotech executives profit from legal insider trading CEOs can legally trade stock in their company as long as they don't use insider knowledge to guide them. And many get remarkably lucky.
07/24/2016
Professor Bob Tufts, who spoke at an EBC event last year, is featured in this article!
From Forest Hills to the bigs and beyond Forest Hills resident Bob Tufts has always been an anomaly.The odds are daunting for anyone who dreams of playing Major League Baseball, but Tufts was able to play for parts of three seasons from 1981 to 1983 for the San Francisco Giants and the Kansas City Royals.